N-ethyl-2-methyl-2-morpholin-4-yl-1-(1-propylimidazol-2-yl)propan-1-amine

C16H30N4O — CID 79051327

IUPACN-ethyl-2-methyl-2-morpholin-4-yl-1-(1-propylimidazol-2-yl)propan-1-amine
SMILESCCCn1ccnc1C(NCC)C(C)(C)N1CCOCC1
InChIInChI=1S/C16H30N4O/c1-5-8-19-9-7-18-15(19)14(17-6-2)16(3,4)20-10-12-21-13-11-20/h7,9,14,17H,5-6,8,10-13H2,1-4H3
InChIKeyDTYHYCJPBXWQOG-UHFFFAOYSA-N
MW294.44 g/mol
LogP2.05
Rot. Bonds7

About N-ethyl-2-methyl-2-morpholin-4-yl-1-(1-propylimidazol-2-yl)propan-1-amine

N-ethyl-2-methyl-2-morpholin-4-yl-1-(1-propylimidazol-2-yl)propan-1-amine (PubChem CID 79051327) has the molecular formula C16H30N4O and a molecular weight of 294.44 g/mol. Its IUPAC name is N-ethyl-2-methyl-2-morpholin-4-yl-1-(1-propylimidazol-2-yl)propan-1-amine.

Molecular Properties

Compound NameN-ethyl-2-methyl-2-morpholin-4-yl-1-(1-propylimidazol-2-yl)propan-1-amine
PubChem CID79051327
Molecular FormulaC16H30N4O
Molecular Weight294.44 g/mol
Exact Mass294.24
IUPAC NameN-ethyl-2-methyl-2-morpholin-4-yl-1-(1-propylimidazol-2-yl)propan-1-amine
SMILESCCCn1ccnc1C(NCC)C(C)(C)N1CCOCC1
InChIInChI=1S/C16H30N4O/c1-5-8-19-9-7-18-15(19)14(17-6-2)16(3,4)20-10-12-21-13-11-20/h7,9,14,17H,5-6,8,10-13H2,1-4H3
InChIKeyDTYHYCJPBXWQOG-UHFFFAOYSA-N
XLogP2.05
TPSA42.32 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds7
Heavy Atoms21
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500294.44
LogP ≤ 52.05
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Analyze N-ethyl-2-methyl-2-morpholin-4-yl-1-(1-propylimidazol-2-yl)propan-1-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-(azepan-1-yl)-N-ethyl-2-methyl-1-(1-methylimidazol-2-yl)propan-1-amine
CID 79050671
[3-methyl-3-morpholin-4-yl-1-(1-propylimidazol-2-yl)butan-2-yl]hydrazine
CID 105240220
1-(1-ethylimidazol-2-yl)-2-methyl-2-morpholin-4-ylpropan-1-amine
CID 79051030
3-[1-(ethylamino)-2-methyl-2-morpholin-4-ylpropyl]pyridin-2-amine
CID 79052607
N-ethyl-3-methyl-1-(1-methylimidazol-2-yl)-3-morpholin-4-ylbutan-2-amine
CID 79762004
2-(azepan-1-yl)-2-methyl-1-(1-propylimidazol-2-yl)propan-1-amine
CID 79051819
N-[(4-ethoxyoxan-4-yl)-(1-propylimidazol-2-yl)methyl]ethanamine
CID 116765859
N-ethyl-2-methyl-1-(1-propylimidazol-2-yl)propan-1-amine
CID 63967916
N-ethyl-2-methyl-2-morpholin-4-yl-1-thiophen-2-ylpropan-1-amine
CID 79052246
1-(2,6-difluorophenyl)-N-ethyl-2-methyl-2-morpholin-4-ylpropan-1-amine
CID 79051927
1-(cyclohexen-1-yl)-N-ethyl-2-methyl-2-morpholin-4-ylpropan-1-amine
CID 106653578
N-ethyl-1-(5-fluoro-3-pyridinyl)-2-methyl-2-morpholin-4-ylpropan-1-amine
CID 79051186

Frequently Asked Questions

What is the IUPAC name of N-ethyl-2-methyl-2-morpholin-4-yl-1-(1-propylimidazol-2-yl)propan-1-amine?
The IUPAC name of N-ethyl-2-methyl-2-morpholin-4-yl-1-(1-propylimidazol-2-yl)propan-1-amine (CID 79051327) is N-ethyl-2-methyl-2-morpholin-4-yl-1-(1-propylimidazol-2-yl)propan-1-amine.
What is the SMILES notation for N-ethyl-2-methyl-2-morpholin-4-yl-1-(1-propylimidazol-2-yl)propan-1-amine?
The canonical SMILES for N-ethyl-2-methyl-2-morpholin-4-yl-1-(1-propylimidazol-2-yl)propan-1-amine is CCCn1ccnc1C(NCC)C(C)(C)N1CCOCC1.
What is the InChIKey of N-ethyl-2-methyl-2-morpholin-4-yl-1-(1-propylimidazol-2-yl)propan-1-amine?
The InChIKey is DTYHYCJPBXWQOG-UHFFFAOYSA-N. The full InChI is InChI=1S/C16H30N4O/c1-5-8-19-9-7-18-15(19)14(17-6-2)16(3,4)20-10-12-21-13-11-20/h7,9,14,17H,5-6,8,10-13H2,1-4H3.
What are the key properties of N-ethyl-2-methyl-2-morpholin-4-yl-1-(1-propylimidazol-2-yl)propan-1-amine?
N-ethyl-2-methyl-2-morpholin-4-yl-1-(1-propylimidazol-2-yl)propan-1-amine has a molecular weight of 294.44 g/mol, XLogP of 2.05, 7 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for N-ethyl-2-methyl-2-morpholin-4-yl-1-(1-propylimidazol-2-yl)propan-1-amine is sourced from PubChem (CID 79051327), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).